For nearly 20 years, I've worked in the digital media sector, with hands-on experience in editorial, marketing, sales and R&D. I'm passionate about engaging and understanding customers to develop great content and products. Formerly Chief Product & Customer Officer at Zapnito, I'm now an advisor to the company.
My background is in technology, professional services and digital media. I co-founded Zapnito due to a number of related observations from my time in these sectors: 1) the social web is creating a huge amount of noise 2) expertise that brands have built up over decades is being drowned out and hidden from those that need it 3) these brands are therefore losing their audience to often undeserving and unhelpful sources, and 4) people are finding it harder to access the expertise that they truly value. I therefore decided to create Zapnito, a white-label platform to help trusted brands reclaim their audiences via expert-driven knowledge networks.
You can consent to the use of such technologies by closing this notice.
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used
to help us achieve the features and activites described below. To learn more about how these trackers help us
These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.
If you are a registered user on Nature Neuroscience - key issues in Alzheimer's Disease, please sign in.
Sign in to Nature Neuroscience - key issues in Alzheimer's Disease
Nature Neuroscience presents a forum on critical issues facing Alzheimer's Disease research today. In a panel discussion, available to view on this site, key researchers in the field considered the support for the pathogenic mechanisms that have been proposed to date, the pros and cons of the current preclinical animal model systems, and the obstacles that the field faces in translating basic discoveries to the clinic. This community has been created to continue this discussion online, allowing for the exchange of ideas between community members. The featured articles in this forum have been made freely available until April 30, 2016 thanks to generous support from Eli Lilly and Company and vTv Therapeutics. Nature Neuroscience is entirely responsible for the selection of the featured content.